These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role. Liblau R. J Neurol Sci; 2009 Dec; 287 Suppl 1():S17-23. PubMed ID: 20106343 [Abstract] [Full Text] [Related]
3. Glatiramer acetate: mechanisms of action in multiple sclerosis. Schrempf W, Ziemssen T. Autoimmun Rev; 2007 Aug; 6(7):469-75. PubMed ID: 17643935 [Abstract] [Full Text] [Related]
4. Glatiramer acetate: mechanisms of action in multiple sclerosis. Ziemssen T, Schrempf W. Int Rev Neurobiol; 2007 Aug; 79():537-70. PubMed ID: 17531858 [Abstract] [Full Text] [Related]
10. A recombinant human IgM promotes myelin repair after a single, very low dose. Warrington AE, Bieber AJ, Ciric B, Pease LR, Van Keulen V, Rodriguez M. J Neurosci Res; 2007 Apr; 85(5):967-76. PubMed ID: 17304578 [Abstract] [Full Text] [Related]
11. Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy. Ziemssen T, Kümpfel T, Schneider H, Klinkert WE, Neuhaus O, Hohlfeld R. J Neurol Sci; 2005 Jun 15; 233(1-2):109-12. PubMed ID: 15869765 [Abstract] [Full Text] [Related]